Treating With Venetoclax for Chronic Lymphocytic Leukemia: Samantha’s Story

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Latest News

Novel Drug Combo Doubles Progression-Free Survival in HER2-Negative Metastatic Breast Cancer

Geriatric Assessments May Open the Door to High-Quality Conversations About Frailty and Aging-Related Concerns in Older Patients With Advanced Cancer

Why I View the Cancer Treatment-Related Changes of My Body With Humor

Black Women With Breast Cancer Have a Higher Risk of Developing Lymphedema Than White Women

View More Latest News

Treating With Venetoclax for Chronic Lymphocytic Leukemia: Samantha’s Story

EP. 1: The First Signs of Leukemia

EP. 2: Chronic Lymphocytic Leukemia Diagnostic Process

EP. 3: CLL Treatment Decision Factors

EP. 4: First-Hand Experience with CD20 Monoclonal Antibody Therapy

EP. 5: CD20 Monoclonal Antibody Dose Adjustment and MRD

EP. 6: The Patient's Role in Deciding a Treatment

EP. 7: Achieving Minimum Residual Disease Remission

EP. 8: Chronic Lymphocytic Leukemia Support Network

EP. 9: Advice for Patient's and Caregivers

EP. 10: Lifestyle Changes After Being Diagnosed with CLL

Latest News